MustGrow inks distribution agreement with Adjuvants Plus Inc. for biological product line
Under the agreement, MustGrow will distribute Adjuvants’ product line across Canada through its recently acquired Canadian sales and distribution division, NexusBioAg.
MustGrow Biologics Corp. a leading provider of biological and regenerative agriculture solutions, is pleased to announce a five-year exclusive distribution agreement was signed with Adjuvants Plus Inc. (“Adjuvants”), a Canadian regenerative agriculture company. Under the agreement, MustGrow will distribute Adjuvants’ product line across Canada through its recently acquired Canadian sales and distribution division, NexusBioAg. MustGrow also has a First Right of Refusal for distribution of Adjuvants’ product line the U.S. market.
This is MustGrow’s first additional product to be added to the existing NexusBioAg product line subsequent to closing the Company’s purchase of NexusBioAg in December 2024. This agreement marks a significant milestone for MustGrow and Adjuvants as they work together to bring innovative, sustainable agricultural solutions to the forefront of North American farming. The partnership reinforces a shared vision for regenerative agriculture and a commitment to enhancing crop productivity while preserving soil health for future generations.
The partnership strengthens MustGrow’s commitment to delivering innovative biological solutions to farmers while expanding its portfolio with Adjuvants’ patented microbial technology featuring Clonostachys rosea, a beneficial fungus that provides plant health and protection benefits (as described more fully below). The agreement includes four key products, with a particular focus on EndoFine® and EndoGuard®, which offer a host of advantages for various crops in North America, including: corn, soybean, edible beans, pulses, canola, cereals (i.e., wheat, barley, oats, and rye), fruits and vegetables, and potatoes.
These products complement MustGrow’s existing crop portfolio, sold in Canada under NexusBioAg, reinforcing the Company’s position as a leader in biological agriculture. The patented Clonostachys rosea technology has been rigorously tested in NexusBioAg’s BioAdvantage Trials Program (“BAT Program”) on multiple crops across Canada over the past two years, demonstrating significant yield increases. With regulatory approvals already in place, MustGrow is poised to launch these products in the Canadian market for the 2025 crop year as well as start the BAT program in the U.S. on fruits & vegetables, targeting California.
“Partnering with Adjuvants aligns perfectly with our vision of advancing sustainable agriculture and providing farmers with innovative biological solutions,” said Corey Giasson, President & CEO of MustGrow. “Through NexusBioAg, our sales and distribution division, we look forward to bringing these solutions to the market and strengthening our relationships with growers across Canada and potentially into the U.S.”
“Levering MustGrow’s distribution platform allows us to bring the benefits of EndoFine® and EndoGuard® to more farmers across Canada,” stated Bill Brown, President Adjuvants. “With a shared commitment to regenerative agriculture, we are confident that these biological solutions will provide long-term benefits to soil health and crop productivity.”
Under the agreement, MustGrow will distribute Adjuvants’